|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 31/381 | (2006.01) |
| A61K 31/4184 | (2006.01) | ||
| A61K 31/4196 | (2006.01) | ||
| A61K 31/513 | (2006.01) | ||
| A61P 31/14 | (2006.01) |
| (11) | Number of the document | 2709613 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12768967.7 |
| Date of filing the European patent application | 2012-09-14 | |
| (97) | Date of publication of the European application | 2014-03-26 |
| (45) | Date of publication and mention of the grant of the patent | 2017-11-29 |
| (46) | Date of publication of the claims translation | 2018-02-12 |
| (86) | Number | PCT/US2012/055621 |
| Date | 2012-09-14 |
| (87) | Number | WO 2013/040492 |
| Date | 2013-03-21 |
| (30) | Number | Date | Country code |
| 201161535885 P | 2011-09-16 | US | |
| 201161561753 P | 2011-11-18 | US |
| (72) |
RAY, Adrian S., US
WATKINS, William J., US
LINK, John O., US
OLDACH, David W., US
DELANEY, IV, William E., US
|
| (73) |
Gilead Pharmasset LLC,
c/o Gilead Sciences, Inc. 333 Lakeside Drive, Foster City, CA 94404,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Žmogaus hepatito viruso (HCV) gydymo būdai |
| METHODS FOR TREATING HCV |
| Payment date | Validity (years) | Amount | |
| 2025-07-24 | 14 | 289.00 EUR |
| 2026-09-14 |